Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
51-200
employees, estimated range
Backers
1
Kurma Partners
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2019 Founded
Registers and programsofficial lists and records that name the company
Legal entity Vico Therapeutics B.V. its site
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Brenig Therapeutics develops innovative small-molecule therapies for neurodegenerative diseases, including LRRK2 inhibitors targeting…
VectoryTxFounded 2020 • 51-200 employees
A biotech company dedicated to developing transformative medicines for people with neurodegenerative diseases using cutting-edge science…
Vergelabs1 role
Verge Labs has spent a decade building one of the most comprehensive proprietary human tissue datasets in neurological disease.
Lario TherapeuticsFounded 2021 • 11-50 employees
Lario Therapeutics are developing first-in-class disease modifying treatments for severe neurological disorders. Precision Neuroscience…
Pangea Bio11-50 employees
Developing transformative medicines for neurological and mental health disorders.
Augustine TherapeuticsFounded 2019 • 11-50 employees
Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular…

Overview

Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly targeting the CAG repea.